SalaryGuide
AboutPricingFor Employers

Marketing jobs

4 marketing jobs

Teleflex logo
5 weeks ago

Sr. Clinical Marketing Manager

Teleflex

Maple Grove, MN (On-site)Full time$133K/yr – $199K/yr
Teleflex logo
2 months ago

Senior Digital Marketing Specialist

Teleflex

Morrisville, NC (Hybrid)
Teleflex logo
3 months ago

Senior Marketing Communications Specialist

Teleflex

Durham, NC (On-site)Full time
Teleflex logo
5 months ago

Senior Marketing Communications Specialist

Teleflex

Durham, NC (Hybrid)Full time

All marketing roles in the US

Get alerts for this search

All marketing roles in the US

Get alerts for this search

4 jobs
Teleflex logo

Sr. Clinical Marketing Manager

Teleflex

Maple Grove, MN (On-site)

$133K/yr - $199K/yrIn-houseFull-timeSenior level5+ years exp.
5 weeks ago
Teleflex logo

Senior Digital Marketing Specialist

Teleflex

Morrisville, NC (Hybrid)

In-houseSenior level5+ years exp.
2 months ago
Teleflex logo

Senior Marketing Communications Specialist

Teleflex

Durham, NC (On-site)

In-houseFull-timeSenior level5+ years exp.
3 months ago
Teleflex logo

Senior Marketing Communications Specialist

Teleflex

Durham, NC (Hybrid)

In-houseFull-timeSenior level3+ years exp.
5 months ago
Teleflex logo
Teleflex

Sr. Clinical Marketing Manager

Maple Grove, MN (On-site)

$133K/yr – $199K/yrSenior Level5+ years expFull time

Posted 5 weeks ago

Top 1% of applicants do these two things.

The other 99% submit and hope. You're about to do something different.

Job Summary

Own clinical education and KOL engagement for cardiovascular devices, turning evidence into customer-ready messaging and scalable HCP programs.

  • Own clinical content and education programs across CMA, Sales, and Global Strategic Marketing to raise NA podium presence.
  • Lead physician education and field feedback loops that inform messaging, assets, and program improvements.
  • Coordinate multi-team logistics and measurement to track HCP engagement and program impact.

Job Description

Responsibilities
  • Serve as a clinical content and coronary and/or peripheral subject matter expert for the commercial team and customers
  • Help translate clinical evidence and product data into clear and engaging messaging
  • Create, update, and maintain clinical education materials, including slide decks and training tools
  • Execute Key Opinion Leader (KOL) engagement activities, fostering strong professional relationships and supporting strategic partnership objectives
  • Work cross-functionally with CMA, Sales leadership, and Global Strategic Marketing to increase North American podium presence
  • Facilitate execution and logistics of HCP-led education programs (e.g., Speaker programs and PCI/CTO Champions) to expand customer knowledge of products and procedures
  • Support the design, content development, and launch of new HCP education programs
  • Execute Teleflex-led programs to deliver consistent, high-quality education across regions
  • Coordinate with internal teams and faculty to support program execution
  • Assist with tracking, reporting, and documentation of program performance and HCP engagement
Requirements
  • Bachelor’s degree required: advanced degree (MBA, MS, MPH, or clinical degree) preferred
  • 5+ years in cardiovascular and/or peripheral medical device marketing, sales, or Clinical
  • Demonstrated experience in Interventional Cardiology and/or Peripheral market
Preferred
  • Proven track record delivering physician education
  • Strong ability to build physician relationships
  • Strong understanding of clinical trial interpretation
Benefits
  • medical, prescription drug, dental, and vision insurance
  • flexible spending accounts
  • participation in a 401(k) savings plan
  • various paid time off benefits, such as PTO, short- and long-term disability, and parental leave
Teleflex logo

Teleflex

3.5 Glassdoor

As a global provider of medical technologies, Teleflex is driven by our purpose to improve the health and quality of people’s lives. Through our vision to become the most trusted partner in healthcare, we offer a diverse portfolio with solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. We believe that the potential of great people, purpose driven innovation, and world-class products can shape the future direction of healthcare. At Teleflex, we are empowering the future of healthcare.Headquartered in Wayne, PA, Teleflex employs over 14,000 people worldwide and serves healthcare providers in more than 150 countries.

Founded in 1943
Wayne, Pennsylvania, USA
9.3K employees (315 in marketing)
www.teleflex.com
67% recommend to a friend
100% CEO approval

Traffic Signals

Monthly Visitors
163.6K
Monthly Google Ads Budget
$6.9K
Traffic Source Mix
Search
46.6%
Direct
40.5%
Referral
7.2%
Social
4.8%
Paid
0.8%

Headcount Trend

Current headcount: ~9.6K

Marketing Team

Marketing Team Size
243 (3% of company)
Marketing Roles Posted (Last 30 Days)
2

Funding

Total Funding
$400M
Last Raise
$400M
Post IPO Debt, 10 years ago

Funding History

  • May 2016
    Post IPO Debt • $400M

Recent News

Teleflex Sells Acute Care, Urology, and Medtech OEM Businesses in $2B Deal
Dec 10, 2025 • PlasticsToday
Teleflex inks deals to sell 3 businesses for $2B
Dec 10, 2025 • MedTech Dive
Teleflex to sell trio of business lines in deals totalling over $2bn
Dec 10, 2025 • Medical Device Network
Q3 Earnings Outperformers: Teleflex (NYSE:TFX) And The Rest Of The Surgical Equipment & Consumables - Specialty Stocks
Dec 10, 2025 • Yahoo Finance
Teleflex Medical to Sell for $1.5B
Dec 9, 2025 • Medical Device and Diagnostic industry
Teleflex inks $2B in divestment deals for OEM, urology and acute care units
Dec 9, 2025 • Fierce Biotech
Teleflex Medical OEM is getting sold to private equity firms
Dec 9, 2025 • Medical Design & Outsourcing
Medical device maker Teleflex to divest three units for $2.03 billion
Dec 9, 2025 • Reuters
Teleflex will sell Acute Care, Urology, OEM businesses for $2.03B
Dec 9, 2025 • MassDevice
Montagu and Kohlberg to acquire Teleflex Medical OEM from Teleflex in a $1.5bn carve-out
Dec 9, 2025 • pehub.com
Teleflex to sell three businesses for $2.03 billion, launches buyback
Dec 9, 2025 • Investing.com
Montagu and Kohlberg to Acquire Teleflex Medical OEM in a Carve-out Transaction
Dec 9, 2025 • Business Wire
Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion
Dec 9, 2025 • GlobeNewswire
Teleflex (TFX): Evaluating Valuation After BIOTRONIK Deal and Recent Share Price Rebound
Dec 7, 2025 • Yahoo Finance
Teleflex at Jefferies Conference: Strategic Restructuring Insights
Nov 18, 2025 • Investing.com
Don't Overlook Teleflex (TFX) International Revenue Trends While Assessing the Stock
Nov 17, 2025 • Yahoo Finance
Teleflex (TFX): Evaluating Valuation Prospects Following Share Price Decline
Nov 15, 2025 • Yahoo Finance
Teleflex to Present at the Jefferies Global Healthcare Conference in London
Nov 14, 2025 • GlobeNewswire
How Teleflex used humor to drive prostate treatment appointments
Nov 10, 2025 • Ad Age
Teleflex (NYSE:TFX) Has Announced A Dividend Of $0.34
Nov 9, 2025 • simplywall.st
Teleflex (TFX) Is Down 12.1% After Goodwill Impairment Drives Steep Net Loss Despite Revenue Growth
Nov 8, 2025 • Yahoo Finance
Teleflex’s (NYSE:TFX) Q3 Sales Top Estimates
Nov 6, 2025 • Yahoo Finance
Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook
Nov 6, 2025 • GlobeNewswire
Teleflex (TFX) Q3 Earnings and Revenues Surpass Estimates
Nov 6, 2025 • Nasdaq
TELEFLEX INC SEC 10-Q Report
Nov 6, 2025 • TradingView
Why Teleflex (TFX) Stock Is Falling Today
Nov 6, 2025 • Yahoo Finance
Teleflex (TFX) Q3 Earnings: What To Expect
Nov 5, 2025 • Yahoo Finance
Teleflex Incorporated (NYSE:TFX) Not Lagging Market On Growth Or Pricing
Oct 30, 2025 • simplywall.st
Teleflex Incorporated Announces Upcoming Conference Call and Virtual Meeting for Q3 Financial Results and Vascular Intervention Business Review | TFX Stock News
Oct 16, 2025 • Quiver Quantitative
Teleflex Announces Third Quarter 2025 Earnings Conference
Oct 16, 2025 • GlobeNewswire
Teleflex Q2 2025 slides: modest growth, raised guidance, strategic progress
Oct 14, 2025 • Investing.com
Teleflex (TFX): Exploring Current Valuation After BIOTRONIK Vascular Intervention Acquisition
Oct 7, 2025 • Yahoo Finance
Why Teleflex (TFX) Stock Is Trading Lower Today
Sep 25, 2025 • Yahoo Finance
With 8.2% CAGR Chronic Total Occlusion Market Size Surges US$ 4.22 billion by 2031 Amid Rising Cardiovascular Disease Burden | The Insight Partners
Sep 23, 2025 • PR Newswire UK
With 8.2% CAGR Chronic Total Occlusion Market Size Surges US$ 4.22 billion by 2031 Amid Rising Cardiovascular Disease Burden | The Insight Partners
Sep 23, 2025 • PR Newswire
A Look Back at Surgical Equipment & Consumables - Specialty Stocks’ Q2 Earnings: Teleflex (NYSE:TFX) Vs The Rest Of The Pack
Sep 18, 2025 • Yahoo Finance
Teleflex Incorporated (TFX) Plans 2026 Split into Two Independent Companies
Sep 16, 2025 • Yahoo Finance
Teleflex In 2025: A Company Trying To Reset (NYSE:TFX)
Sep 14, 2025 • Seeking Alpha
Teleflex enrols first patient in DUBSTENT DIABETES trial
Sep 12, 2025 • Medical Device Network
The past five years for Teleflex (NYSE:TFX) investors has not been profitable
Sep 12, 2025 • Yahoo Finance
Teleflex enrolls first patient in dual-drug-eluting device study of coronary interventions for diabetes
Sep 11, 2025 • MassDevice
First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients
Sep 11, 2025 • BioSpace
First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients
Sep 11, 2025 • Morningstar.com
First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients
Sep 11, 2025 • Teleflex Incorporated
global lung cancer surgery market
Sep 11, 2025 • PharmiWeb
Teleflex says first patient enrolled in DUBSTENT DIABETES trial
Sep 11, 2025 • thefly.com
Teleflex at Morgan Stanley Conference: Strategic Reorganization and Growth Plans
Sep 9, 2025 • Investing.com
Transcript : Teleflex Incorporated Presents at Morgan Stanley 23rd Annual Global Healthcare Conference, Sep-09-2025 03
Sep 9, 2025 • MarketScreener
Hempel buys Maple Grove medical lab, signs Laborie as tenant
Sep 9, 2025 • Seattle TechFlash
Ureteral Stents Market is Poised to Attain Valuation of US$ 685.05 Million by 2033 | Astute Analytica
Sep 3, 2025 • AstuteAnalytica India Pvt. Ltd.
Global Specimen Retrieval Market Set to Reach USD 1.8 Billion by 2034
Sep 2, 2025 • EIN Presswire
Teleflex (TFX): Buy, Sell, or Hold Post Q2 Earnings?
Aug 27, 2025 • Yahoo Finance
Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
Aug 26, 2025 • Yahoo Finance
Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
Aug 26, 2025 • Teleflex Incorporated
Teleflex Stock Gains Following Barrigel's Launch in Japan
Aug 21, 2025 • Yahoo Finance
Teleflex and Vitality Road executives lead movement to improve women’s heart health in Greater Boston
Aug 19, 2025 • www.heart.org
Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy
Aug 19, 2025 • MarketScreener
Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy
Aug 19, 2025 • Teleflex Incorporated
U.S. IV Infusion Products Market Set to Witness Significant Growth by 2025-2032 |Kimal, Terumo Corporation, Teleflex Inc
Aug 14, 2025 • EIN Presswire
Teleflex’s Q2 Earnings Call: Our Top 5 Analyst Questions
Aug 13, 2025 • Yahoo Finance
Venous Stents Market to Reach $2.62B by 2033, Fueled by Minimally Invasive Trends and Aging Populations
Aug 12, 2025 • EIN Presswire
Medical Devices Market Poised for Major Shift – Key Players and Trends Uncovered
Aug 11, 2025 • EIN Presswire
Just Four Days Till Teleflex Incorporated (NYSE:TFX) Will Be Trading Ex-Dividend
Aug 10, 2025 • simplywall.st
Tip Location Devices Market Insights, Competitive Landscape, and Forecast Report 2024-2032 | BD and Teleflex Advance ECG-based and Ultrasound Systems, with North America Leading the Market
Aug 8, 2025 • Research and Markets
Medical Devices Market Growth Accelerates as Demand Surges Across Key Industries
Aug 7, 2025 • EIN Presswire
Robotic Endoscopy Device Market Set to Reach USD 10.0 Billion, with a Healthy 9.05% CAGR Till Forecasts 2035
Aug 6, 2025 • EIN Presswire
Teleflex closes $879M Biotrionik buy, wraps strong Q2
Aug 4, 2025 • BioWorld MedTech
Results: Teleflex Incorporated Exceeded Expectations And The Consensus Has Updated Its Estimates
Aug 4, 2025 • simplywall.st
Teleflex Incorporated Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Aug 3, 2025 • Yahoo Finance
Teleflex Second Quarter 2025 Earnings: Beats Expectations
Aug 2, 2025 • Yahoo Finance
Teleflex (TFX) Q2 Earnings and Revenues Top Estimates
Jul 31, 2025 • Nasdaq
Teleflex Raises 2025 Guidance After BIOTRONIK Acquisition
Jul 31, 2025 • TipRanks
Teleflex Announces Quarterly Dividend
Jul 31, 2025 • GlobeNewswire
Teleflex (NYSE:TFX) Beats Q2 Sales Targets
Jul 31, 2025 • Yahoo Finance
Earnings call transcript: Teleflex Q2 2025 earnings beat boosts stock
Jul 31, 2025 • Investing.com
Teleflex Non-GAAP EPS of $3.73 beats by $0.36, revenue of $780.9M beats by $9.37M
Jul 31, 2025 • Seeking Alpha
Teleflex Reports Second Quarter Financial Results and Full Year 2025 Outlook
Jul 31, 2025 • Morningstar.com
Teleflex Announces Quarterly Dividend
Jul 31, 2025 • Morningstar.com
Teleflex raises FY25 adjusted EPS view to $13.90-$14.30 from $13.20-$13.60
Jul 31, 2025 • thefly.com
Teleflex Reports Second Quarter Financial Results and Full Year 2025 Outlook
Jul 31, 2025 • Teleflex Incorporated
Thrombectomy Devices Market to Reach $2.31B by 2031, Fueled by Stroke Burden and Tech Innovation
Jul 30, 2025 • EIN Presswire
Global Urinary Drainage Bags Market: Growth Path, Drivers, and Future Potential (2021–2031)
Jul 30, 2025 • EIN Presswire
Teleflex (TFX) To Report Earnings Tomorrow: Here Is What To Expect
Jul 29, 2025 • Yahoo Finance
Are Teleflex Incorporated's (NYSE:TFX) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?
Jul 28, 2025 • simplywall.st
Chest Drainage Catheters Market Insights, Competitive Landscape, and Forecast Report 2025-2032 Featuring Leading Players - BD, Teleflex, Cook, ICU Medical, and Redax
Jul 25, 2025 • Research and Markets
Analysts Estimate Teleflex (TFX) to Report a Decline in Earnings: What to Look Out for
Jul 24, 2025 • Yahoo Finance
Teleflex stock hits 52-week low at 110.83 USD
Jul 21, 2025 • Investing.com
Vascular Access Devices Company Evaluation Report 2025 | Becton Dickinson, Teleflex, and ICU Medical Strengthen Global Leadership Through Strategic Acquisitions and Product Innovation
Jul 18, 2025 • Research and Markets
Teleflex Announces Second Quarter 2025 Earnings Conference Call Information
Jul 17, 2025 • Teleflex Incorporated
Global Healthcare Advances Drive Peripheral IV Catheters Market, Forecasted to Grow at 4.8% CAGR Through 2035
Jul 15, 2025 • EIN Presswire
Ureteral Obstruction Market is Set to Globally Reach US$ 1.39 Billion 2032, at CAGR 7.10% To Forecast 2025-2032
Jul 11, 2025 • EIN Presswire
High Flow Nasal Cannula Market to Reach USD 13.30 Billion by 2030, Says Mordor Intelligence
Jul 10, 2025 • EIN Presswire
Needham maintains Hold rating on Teleflex stock after Biotronik acquisition
Jul 8, 2025 • Investing.com
Vascular Access Device Market Projected to Reach USD 8.18 Billion by 2032, Growing at a CAGR of 6.64% To 2025-2032
Jul 8, 2025 • EIN Presswire
Procedure Trays Market Size Projected to Exceed USD 49.32 Billion by 2031 at a 10.2% CAGR, Driven by Increasing Surgical Procedures and Emphasis on Infection Control | The Insight Partners'
Jul 7, 2025 • PR Newswire
Procedure Trays Market Size Projected to Exceed USD 49.32 Billion by 2031 at a 10.2% CAGR, Driven by Increasing Surgical Procedures and Emphasis on Infection Control | The Insight Partners'
Jul 7, 2025 • prnewswire.co.uk
Intraosseous Infusion Devices Market to Surpass USD 8.79 Billion by 2032, Exhibiting Robust 6.2% CAGR To 2025-2032
Jul 4, 2025 • EIN Presswire
Teleflex Acquires BIOTRONIK's Vascular Intervention Business, Stock Up
Jul 3, 2025 • Nasdaq
Teleflex Acquires BIOTRONIK's Vascular Intervention Business, Stock Up
Jul 3, 2025 • Yahoo Finance
Teleflex finalizes acquisition of Biotronik
Jul 2, 2025 • Mobi Health News